secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARDELYX, INC. (ARDX)
CIK:        0001437402
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001628280-25-037441
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardelyx Q2 revenue $97.7M (+33%), raises IBSRELA guidance; CFO to depart
------------------------------------------------------------------------

- Q2 total revenue $97.7M (+33% YoY); IBSRELA net sales $65M (+84% YoY); XPHOZAH net sales $25M (-33% YoY).
- Raised FY2025 IBSRELA U.S. net sales revenue outlook to $250-260M from prior guidance.
- Net loss $19.1M ($0.08/sh) vs $16.5M ($0.07) YoY; cash & investments $238.5M at June 30, 2025.
- CFO Justin Renz to transition out by Dec 31, 2025 or upon new CFO start; transition agreement signed.
- Drew $48.7M net from SLR term loan; option to draw additional $100M in two tranches.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1437402/000162828025037441/0001628280-25-037441-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1437402/000162828025037441/ardx-20250801.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-037441

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer